Dear E-druggers,
Attached is the text of a January 13, 1997 FDA talk paper on withdrawing
the marketing approval for terfenadine in the U.S. This should be of
interest to E-Drug subscribers in other countries in which terfenadine is
licensed.
Warmest regards,
Larry
Larry D. Sasich, Pharm.D., FASHP
Public Citizen Health Research Group
1600 20th Street NW
Washington, DC 20009, USA
Voice: 202-588-7782
FAX: 202-588-7796
E-Mail: lsasich@citizen.org